CJC-1295 is a synthetic GHRH analog peptide that stimulates the pituitary gland to increase natural growth hormone and IGF-1.
CJC-1295 is a synthetic GHRH analog peptide that stimulates the pituitary gland to increase natural growth hormone and IGF-1. The DAC version binds albumin for a 6-8 day half-life and sustained elevation, while CJC-1295 no DAC (Mod GRF 1-29) offers a 30-minute half-life and pulsatile release. Human Phase 1 studies showed 2-10 fold GH increases lasting over six days after one dose. Researchers use CJC-1295 for studies on recovery, sleep quality, and body composition. Not FDA-approved and WADA-banned, this research peptide is commonly stacked with Ipamorelin. Choose high-purity CJC-1295 DAC or no-DAC for laboratory use only.